Pre-Annual General Meeting Information • Mar 21, 2018
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer
If you are in any doubt as to any aspect of the proposals referred to in this document, or as to the action you should take, you should seek your own advice from a stockbroker, solicitor, accountant or other independent financial adviser who, if you are taking advice in the United Kingdom, is duly authorised under the Financial Services and Markets Act 2000 or an appropriately authorised independent financial adviser if you are in a territory outside the United Kingdom.
If you have sold or otherwise transferred all of your shares in the Company, please pass this document together with the accompanying document(s) to the purchaser or transferee, or to the person who arranged the sale or transfer so they can pass these documents to the person who now holds the shares.
Elementis plc (the 'Company') (registered in England & Wales no 3299608) Caroline House 55-57 High Holborn London WC1V 6DX
7 March 2018
Dear Shareholder
I am writing to give you notice of the Company's AGM that is to be held at the offices of Herbert Smith Freehills LLP, Exchange House, Primrose Street, London EC2A 2EG on Thursday 26 April 2018 at 11.00 am.
As you will see from the notice of AGM overleaf, there are a number of items of business to be considered and you will find explanatory notes for each resolution on pages 4 to 8.
The directors believe that in the interests of shareholder democracy, it is important that the voting intentions of all members are taken into account, not just those who are able to attend the AGM and as such we propose putting all resolutions to shareholders by way of poll rather than a show of hands. Shareholders attending the AGM will still have the opportunity to ask questions and vote on each resolution.
If you would like to vote on the resolutions but cannot come to the AGM, you can appoint a proxy to exercise all or any of your rights to attend, vote and speak at the AGM. You will find a Form of Proxy and an Attendance Card enclosed with this notice. Alternatively, submit an electronic proxy appointment instruction as soon as possible and, in any event, so as to be received by the Company's Registrar at the relevant address set out below by no later than 11.00 am on 24 April 2018. Completion and return of the Form of Proxy or submission of an electronic instruction will not preclude you from attending and voting in person at the AGM should you subsequently decide to do so.
If you have any questions about the AGM or your shareholding, please contact our Registrar, Equiniti, by post at Equiniti Limited, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA; by telephone on 0371 384 2379 (overseas +44 121 415 7043; or for shareholders who have already registered with Equiniti's online portfolio service; Shareview, on the internet at www.shareview.co.uk (lines are open from 8.30 am to 5.30 pm Monday to Friday excluding public holidays in England and Wales). Further shareholder information can be found on the Company's corporate website at www.elementisplc.com
The Board confirms that, in its opinion, all of the resolutions are in the best interests of the Company and its shareholders as a whole and unanimously recommends that shareholders vote in favour of them. The directors intend to vote in favour of the resolutions in respect of their own beneficial shareholdings.
Yours sincerely
ANDREW DUFF Chairman
Notice is hereby given that the 2018 Annual General Meeting ('AGM' or the 'Meeting') of the Company will be held at the offices of Herbert Smith Freehills LLP, Exchange House, Primrose Street, London EC2A 2EG on Thursday 26 April 2018 at 11.00 am to transact the business set out below.
Resolutions 1 to 16 and 21 to 22 will be proposed as ordinary resolutions and resolutions 17 to 20 will be proposed as special resolutions.
such authorities to apply in substitution for all previous authorities pursuant to Section 551 of the Companies Act and to expire at the end of the next AGM or on 26 July 2019, whichever is the earlier but, in each case, save that the Company may make offers and enter into agreements during the relevant period which would, or might, require shares to be allotted or rights to subscribe for or to convert any security into shares to be granted after the authority ends.
For the purposes of this Resolution:
(as such terms are defined in Sections 363 to 365 of the Companies Act 2006) provided that the aggregate amount of any such donations and expenditure shall not exceed £50,000 during the period beginning with the date of passing this resolution and expiring at the conclusion of the next AGM of the Company or until the close of business on 26 July 2019, whichever is earlier provided that the authorised sums referred to in paragraphs a), b) and c) above, may be comprised of one or more amounts in different currencies which, for the purposes of calculating the said sums, shall be converted into pounds sterling at the exchange rate published in the London edition of the Financial Times on the date on which the relevant donation is made or expenditure incurred (or the first business day thereafter) or, if earlier, on the day on which the Company enters into any contract or undertaking in relation to the same.
such authority to expire at the end of the next AGM of the Company or on 26 July 2019, whichever is the earlier, save that prior to its expiry, the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the authority had not expired.
such authority to expire at the end of the next AGM of the Company or on 26 July 2019, whichever is the earlier, save that prior to its expiry, the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the authority had not expired.
By Order of the Board
Registered office: Caroline House, 55-57 High Holborn, London WC1V 6DX The Notice of AGM appears on pages 2 to 3. The following information provides additional background information to several of the resolutions proposed.
The Companies Act 2006 requires the directors of a public company to lay before the company in general meeting copies of the annual report and accounts in respect of each financial year. In accordance with the UK Corporate Governance Code, the Company proposes a resolution on its audited accounts and directors' and auditors' reports for the year ended 31 December 2017. Shareholders will have the opportunity to put any questions to the directors before the resolution is proposed to the Meeting.
The directors recommend a final dividend in respect of 2017 of 6.10 cents per share. The final dividend will be paid on 1 June 2018 in pounds sterling at an exchange rate of £1.00:\$1.4035 (equivalent to a sterling amount of 4.3463 pence per share), to shareholders on the register of members of the Company on 4 May 2018. A copy of the Company's dividend policy is set out on pages 2 to 3 of the annual report and accounts.
The Company is required, pursuant to the Companies Act 2006, to put its directors' remuneration policy to shareholders for approval at the AGM this year, having been three years since the Company's current directors' remuneration policy was approved by shareholders (at the AGM in 2015). The proposed directors' remuneration policy is set out on pages 58 to 66 of the directors' remuneration report. The new policy has been updated in light of current best practice, with the proposed changes designed to provide further alignment of directors' remuneration with the long term future of the Company and the interests of shareholders. A summary of the changes proposed can be found on pages 55 to 57 of the annual report and accounts. The proposed policy has been developed following dialogue with a range of our largest shareholders and institutional investor groups.
The vote on this resolution is binding and, if passed, the new directors' remuneration policy will apply immediately following the AGM, and will replace the current directors' remuneration policy. The new directors' remuneration policy will be effective for three financial years without the need for a new shareholder approval, unless any amendments are proposed to it. The directors will only be able to make remuneration payments in accordance with the approved new policy unless any other payments have been approved by a separate shareholder resolution. If resolution 3 is not passed, the current remuneration policy approved at the AGM in 2015 will continue in effect (until a new policy is approved by shareholders).
This vote will be proposed as an advisory vote to approve the directors' remuneration report for 2017 (excluding the remuneration policy). An advisory vote means the outcome will not affect the actual remuneration paid to any individual director.
In accordance with the provisions of the UK Corporate Governance Code concerning the annual re-election of all directors of FTSE 350 companies,all the directors, will be retiring at the AGM and offer themselves for re-election by shareholders.
The Board and the Nomination Committee have discussed the Board's succession plans and all non-executive directors, including the Chairman, have indicated their willingness to be re-appointed. Following these discussions and its annual performance evaluation, the Board is satisfied that all our directors, both executives and non-executives, contribute effectively and demonstrate appropriate commitment to their role and, therefore, shareholders are asked to support their re-election at the AGM.
Biographical details of each of the directors standing for re-election are set out below.
Andrew joined the Board as a non-executive director and deputy Chairman on 1 April 2014 and was appointed non-executive Chairman and chairman of the nomination committee on 24 April 2014.
Andrew has a demonstrable track record in delivering value to customers and shareholders through significant boardroom experience gained from large listed companies. This combined with experience in the manufacturing, energy and utilities sectors enables Andrew to lead the Elementis Board. From 2003 until 2009, he was chief executive officer of Npower, the successor entity to Innogy plc which in 2000 was demerged from, restructured and then sold by National Power to RWE, the German electricity and gas company. Andrew was also a member of the RWE's executive committee. Before this Andrew spent 16 years at BP in downstream international markets. Andrew has also been a non-executive director of Wolseley plc, the international plumbing and building materials company, between 2004 and December 2013, where he was also the senior independent director and chairman of the remuneration committee.
Andrew holds a BSc (Honours) degree in Mechanical Engineering and is a fellow of the Energy Institute.
N*
British
Paul was appointed Group CEO on 8 February 2016.
Paul has a proven track record in developing markets, products and opportunities for creating value, business optimisation and transformation. Prior to joining Elementis, Paul was global CEO of the BP lubricants business in 2013 after having overseen the BP Australia/New Zealand downstream business. In 2010, Paul was country president of BP Australia. Prior to this he was CEO of BP's global aviation, industrial, marine and energy lubricants businesses (2009 to 2010) and CEO of BP Lubricants Americas (2007 to 2009). He joined BP after it acquired Burmah-Castrol in 2000, having joined the latter in 1994 after roles at Reckitt Benckiser and Kraft Foods.
Paul holds a BSc degree in Packaging Engineering from Michigan State University and an MBA in Finance and International Business from New York University, Stern School of Business.
American
Ralph was appointed CFO-Designate and an executive director on 12 September 2016, and became Group CFO on 1 November 2016.
Ralph is an accomplished CFO who has a strong track record in finance, strategy development and implementation, and mergers and acquisitions. During his 30 year career with BP, Ralph held a number of significant leadership positions, including roles in financial management, sales and marketing, corporate development (M&A), strategy and planning. In 2010, Ralph was CFO of BP Lubricants and served on the board of Castrol India Limited from 2010 until 2016.
Ralph holds an MA degree in Modern History and Economics from the University of Oxford and an MBA from INSEAD.
British
Sandra was appointed a non-executive director on 1 February 2017.
Sandra brings strategic experience gained as a consultant to complex global companies on transformational change. She was a senior partner at McKinsey & Company from 2005 to 2014 (and a partner from 2000), where she specialised in investment banking and risk, and held several senior management positions in the UK and the US. At McKinsey, Sandra acted as an adviser to global financial institutions, corporates and public sector bodies on a wide range of strategic, operational and policy issues. Sandra has held other non-executive and advisory appointments with the Institute of International Finance, the McKinsey Master Retirement Trust and the Edith Wharton Restoration.
Sandra has a BA degree in American Studies and Economics from Stanford University and an MBA degree from Harvard Business School.
A, N, R
– External member of the Bank of England's Prudential Regulation Committee (from September 2014) and an independent member of the executive committee of the Bank that oversees the real time gross settlement service and high value payment system (from November 2017)
– A non-executive director of Enstar Group Ltd (from November 2015), chairman of the risk committee and a member of the compensation and nominating committees
British/American
Dorothee was appointed a non-executive director on 1 March 2017.
Dorothee's background is in corporate finance with experience in the broader chemicals sector. She manages her own corporate advisory consultancy serving a number of European clients in the pharma/ biotech sector. She is active in various industry bodies. Her previous executive roles included managing director and head of Corporate Advisory Group (Europe) at UBS in Zurich, head of M&A chemicals and healthcare at a private investment bank in Germany and as a senior executive in the corporate finance department at the Roche group.
Dorothee holds a masters degree in Chemistry from the Université Louis Pasteur, Strasbourg and an MBA from INSEAD.
A, N, R
Austrian
Steve was appointed a non-executive director on 20 October 2014 and became chairman of the remuneration committee on 25 April 2017.
Steve has international experience in specialty chemicals businesses, manufacturing and diverse industrial markets. Steve was chief executive of Low & Bonar plc between September 2009 and September 2014. Prior to that role, he was managing director of its technical textiles division between 2006 and 2009, director of new business between 2005 and 2006, and managing director of its plastics division between 2004 and 2005. Prior to joining Low & Bonar he spent 10 years with BTP plc (now part of Clariant) in a variety of leadership positions managing international speciality chemicals businesses. He was also non-executive director and chairman of the remuneration committee of Cape plc from July 2015 to September 2017.
Steve holds a degree in Economics and Financial Management from Sheffield University. He is a chartered accountant.
British
Anne was appointed a non-executive director in June 2013 and became chairman of the audit committee on 1 August 2013.
Anne brings substantial financial expertise to the Board. She is currently CFO of Kymab Ltd, a biopharmaceutical company funded by the Wellcome Trust and the Bill & Melinda Gates Foundation. Prior to her current executive role, she was CFO and company secretary of BBI Diagnostics Group Ltd and FTSE-listed Vectura Group plc. Previous senior finance positions held include director of corporate finance at Celltech Group plc, Medeva plc and KPMG.
Anne holds a degree in Business Studies from Trinity College, Dubin and is a chartered accountant (FCA) and a corporate tax adviser (CTA – AITI).
Committee membership A*, N
– Non-executive director of Clinigen Group plc (from January 2018) and chairman of the audit committee
Nationality Irish
Nick was appointed a non-executive director on 20 October 2014 and became senior independent director on 16 December 2014.
Nick brings extensive experience both as a non-executive director and as an accomplished executive. He has been responsible for leading several major restructuring projects and negotiating complex acquisitions and disposals. He was chief executive of Cookson Group plc from July 2004 to December 2012 when Cookson demerged to create two new listed companies, Vesuvius plc and the specialty chemicals company, Alent plc. He was formerly executive vice-president of Alstom S.A. and chief executive of Babcock International Group plc. He held other senior management positions at GEC and GEC Alsthom and the China Light and Power Company.
Nick served as a non-executive director of United Utilities plc from 2005 to 2014 where he was also senior independent director from 2007 onwards.
Nick holds a degree in Mechanical Engineering and is a fellow of the Royal Academy of Engineering.
Committee membership A, N, R
Resolution 13 relates to the re-appointment of Deloitte LLP as the Company's auditor to hold office until the next AGM of the Company. This resolution is recommended by the Audit Committee and endorsed by the Board. The directors propose the re-appointment of Deloitte LLP. The rationale for this recommendation can be found in the annual report on page 53.
Resolution 14 authorises the Audit Committee of the Board to set the auditor's remuneration. The Audit Committee considers that the nature and level of consultancy-related non-audit fees to audit fees undertaken by Deloitte LLP (which are detailed on page 53 of the annual report) is in accordance with the Company's non-audit services policy, is appropriate for the advisory work required to be undertaken for the year ended 31 December 2017 and that they do not impact on the auditor's objectivity and independence.
Under the Companies Act 2006 and Article 4.2 of the Company's Articles of Association, the directors may only allot equity securities (being ordinary shares in the capital of the Company or grant rights to subscribe for or convert any security into shares), if authorised to do so by shareholders in general meeting. At last year's AGM held on 25 April 2017, shareholders granted the directors such authority to allot equity securities.
Part (a) of Resolution 15 seeks to renew that authority to allow the directors to allot equity securities up to an aggregate nominal amount of £7,732,370 representing an amount equal to one-third of the Company's issued share capital, excluding any shares held by the Company in treasury ('Treasury Shares'), as at 5 March 2018 the latest practicable date prior to the printing of this document. The Company holds no such Treasury Shares.
In addition, the Company is seeking authority in part (b) of Resolution 15 to allow the directors to allot equity securities only in connection with a rights issue up to a further nominal value of £7,732,370, representing an amount equal to one-third of the Company's issued share capital, excluding Treasury Shares, as at 5 March 2018.
The authority being sought in Resolution 15 complies with the latest guidelines issued by the Investment Association. If Resolution 15 is passed, the directors will have the authority in certain circumstances to allot equity securities up to a total nominal value of £15,464,740, representing a total amount equal to two-thirds of the Company's issued share capital, excluding Treasury Shares, as at 5 March 2018.
The directors have no present intention of exercising the authority in Resolution 15. The directors consider it desirable to have the maximum flexibility permitted by corporate governance guidelines to manage the Company's share capital base. The authority granted in Resolution 15 will expire on the date of the Company's next AGM or 26 July 2019, whichever is the earlier.
This special resolution will renew the authority granted to the Group in last year's AGM to make donations to political parties, independent election candidates and political organisations and to incur political expenditure.
The Group's policy is generally to prohibit direct or indirect political contributions and the directors have no intention of using this authority for the above purpose. What constitutes a political donation, a political party, a political organisation, or political expenditure is not easy to define, as the legislation is capable of wide interpretation. Sponsorship, subscriptions, payment of expenses, paid leave for employees fulfilling public duties, and support for bodies representing the business community in policy review or reform, may fall within this.
Accordingly, the directors have decided to seek shareholder authority for political donations and political expenditure in case any of our normal business activities are caught by the legislation. As permitted by Part 14 of the Companies Act 2006, the resolution covers any political donations made, or political expenditure incurred, by any subsidiaries of the Company. The Companies Act 2006 covers three categories: political parties and independent election candidates, political organisations and political expenditure. The directors have decided to place a cap of £50,000 per category provided that authorised political donations or political expenditure do not exceed in aggregate £50,000. The authority will expire at the conclusion of the next AGM or 26 July 2019 (whichever is earlier) and the directors expect to seek to renew this authority at each AGM.
This special resolution, if renewed, will allow the Company to call general meetings, other than the AGM, on 14 clear days' notice. The reduction in notice period to 14 days may be advantageous to the Company should it require to seek shareholder approval on any matter. However, the shorter notice period would not be routine but used only for general meetings if the Board considers that the flexibility is merited by the business of the meeting and the circumstances surrounding the business, or to keep a period of uncertainty about the future of the Company to a minimum. Examples of when the directors may consider it appropriate to call a general meeting at 14 days' notice include when significant time sensitive transactions or other price sensitive transactions are being put to shareholders for approval.
Under the Companies Act 2006 and Article 4.4 of the Company's Articles of Association, the directors may seek approval from shareholders to waive the application of statutory pre-emption rights such that the allotment of equity securities pursuant to the authority granted in Resolution 15 may be made without first having to offer it to existing shareholders in proportion to their existing holdings.
At last year's AGM shareholders passed two special resolutions in relation to the disapplication of statutory pre-emption rights.
This year, and in line with the Pre-Emption Group's Statement of Principles on the Disapplication of Pre-Emption Rights (the Pre-emption Group Principles) the directors have proposed again two separate resolutions to disapply pre-emption rights.
Resolution 18 will permit the directors to use the authority in Resolution 15 to allot:
Resolution 19 will permit the directors to allot additional equity securities up to a maximum nominal value of £1,159,855, representing approximately a further 5 per cent of the issued ordinary share capital of the Company as at 5 March 2018 (the latest practicable date prior to publication of this document), otherwise than in connection with a pre-emptive offer to existing shareholders for the purposes of financing or refinancing a transaction as contemplated by the Pre-emption Principles. The directors believe that it is appropriate to seek this additional 5 per cent authority in Resolution 19 to give the Company the flexibility that this resolution affords.
The Board confirms that, in accordance with the Pre-Emption Principles, it does not intend to issue shares for cash representing more than 7.5 per cent of the Company's issued ordinary share capital in any rolling three-year period to those who are not existing shareholders (save in accordance with Resolution 19) without prior consultation with shareholders. If passed, the authorities given in Resolution 18 and 19 will expire on the date of the Company's next AGM or 26 July 2019, whichever is the earlier.
The directors do not currently intend to allot equity securities for cash on a non pre-emptive basis pursuant to the authority in Resolution 18 and 19.
This special resolution will renew the Company's authority to make market purchases of its ordinary shares on the London Stock Exchange until the Company's next AGM or, if earlier, until 26 July 2019. The directors have no plans at present to exercise such authority and, in any event, would only do so where they believe such purchases would result in an increase in earnings per share and would be in the best interests of shareholders generally. The authority will allow the Company to purchase up to 46,394,223 ordinary shares, representing 10 per cent of the Company's issued share capital as at 5 March 2018, the latest practicable date prior to the printing of this document. The Resolution also sets out the maximum and minimum price at which any such purchase may be made.
The Company is able to hold shares purchased under this authority in treasury with a view to selling them later on, rather than cancelling them. This provides the Company with additional flexibility in the management of its capital base. For so long as any such shares are held in treasury no dividends will be paid on them and no voting rights will attach to them. If Resolution 20 is passed, it is the Company's current intention to cancel the shares it may purchase pursuant to the authority granted to it. However, in order to respond properly to the Company's capital requirements and prevailing market conditions, the directors will reassess at the time of any and each actual purchase whether to hold the shares in treasury or cancel them, provided it is permitted to do so.
The number of unissued shares that were subject to subscription options as at 5 March 2018 was approximately 6,559,000. This equals, in number, 1.41 per cent of the Company's issued shares at that date. If the proposed share purchase authority were to be exercised in full, those 6,559,000 shares would represent 1.57 per cent of the issued shares as reduced by the share purchases. As at 5 March 2018, the latest practicable date prior to the printing of this document, the Company was authorised to make market purchases of up to 46,363,588 ordinary shares pursuant to an ordinary resolution passed at the 2017 AGM on substantially the same terms as those set out in Resolution 20.
(together the 'New Share Schemes')
The New Share Schemes replace the Company's existing share schemes ('Old Share Schemes') that will expire in 2018. Shareholder approval is sought for the approval of the New Share Schemes at the AGM to ensure that the Company has the appropriate share incentives and that they operate consistently with the revised directors' remuneration policy. No new awards will be made under the Old Share Schemes after the date of the AGM, provided shareholder approval is obtained for the New Share Schemes.
The principal terms of the New Share Schemes are set out in this document on pages 9 to 11.
There are no material differences between the New Share Schemes and Old Share Schemes save that under the proposed LTIP 2018 there is the ability to grant restricted shares to employees below Board level (i.e. shares that vest based on time only) in addition to the current approach of granting performance related share awards. This revised approach reflects the fact that most participants in the proposed LTIP 2018 will be based in the U.S. where it is common practice to grant restricted shares. Taking this approach will enable the Company to better compete for the best talent in the U.S. and offer greater flexibility to reward and incentivise our key below Board talent more generally.
Under each resolution authority is also being sought to allow supplementary plans to the LTIP 2018 and UK SAYE Scheme 2018 to be established for benefit of employees of the Company (or any of its subsidiaries) who are resident or working outside the UK and for whom participation in the LTIP 2018 and UK SAYE Scheme 2018 is otherwise impractical.
The rules of the New Share Schemes will be available for inspection during normal business hours on Monday to Friday (excluding UK public holidays) at the Company's registered office from the date of this document until the close of the AGM and at the offices of Herbert Smith Freehills LLP, Exchange House, Primrose Street, London EC2A 2EG for at least 15 minutes before the AGM and during the AGM.
See Note 9 to the Notice of Meeting on page 12.
The LTIP 2018 will be administered by the remuneration committee of the board of directors of the Company (the 'Remuneration Committee').
Employees (including executive directors) of the Company or of any of its subsidiaries will be eligible to participate in the LTIP 2018.
The LTIP 2018 is an 'umbrella' arrangement which, to give the Committee maximum flexibility, allows different types of award to be granted.
It is intended that the LTIP 2018 will be used annually to grant 'Performance Share Awards' in respect of ordinary shares to the executive directors of the Company and other members of senior management. Performance Share Awards must be granted subject to performance targets.
It is currently intended that the first grant of Performance Share Awards be made within six weeks of shareholder approval of the LTIP 2018 at the AGM.
The LTIP 2018 also gives the Committee the ability to grant 'Restricted Stock Awards' which may be granted in the same form as Performance Share Awards but which will not be subject to performance targets.
It is currently intended that Restricted Stock Awards will be granted annually to certain members of senior management below Board level. Where Restricted Stock is granted, it is expected that award levels will be lower than if Performance Shares Awards were to be granted since these awards are more valuable to a recipient given there is no performance target attached to the vesting of the award. There is no intention that Restricted Stock will be granted to executive directors
The LTIP 2018 contains an individual limit which provides that the market value of ordinary shares that may be awarded to any one participant in any financial year under all forms of award cannot exceed 250 per cent of annual base salary.
Awards may be satisfied by newly issued ordinary shares or ordinary shares purchased in the market by an employees' trust or by the transfer of ordinary shares held in treasury.
The number of new ordinary shares issued or remaining capable of being issued pursuant to awards under the LTIP 2018 and all of the Company's other employee share schemes in any period of ten years will not exceed 10 per cent of the ordinary share capital of the Company in issue from time to time.
The number of new ordinary shares issued or remaining capable of being issued pursuant to awards granted under the LTIP 2018 and the Company's other discretionary share schemes in any period of ten years will not exceed 5 per cent of the ordinary share capital of the Company in issue from time to time.
If awards are to be satisfied by a transfer of existing ordinary shares, the percentage limits stated above will not apply. Insofar as it is necessary to ensure compliance with the guidelines issued from time to time by institutional investors, the percentage limits will apply to awards satisfied by the transfer of ordinary shares held in treasury.
Awards may be granted during the six weeks immediately following the AGM. Thereafter, awards may only be granted:
No awards may be made more than ten years after shareholder approval of the LTIP 2018. No payment will be required for the grant of an award.
As noted in section 3 above, Performance Share Awards will always be subject to performance targets.
It is intended that the first set of Performance Share Awards to be granted to the executive directors of the Company will be subject to performance targets relating to earnings per share ('EPS') and total shareholder return ('TSR') measured in each case between 1 January 2018 and 31 December 2020.
50 per cent of each of these awards will be subject to a performance target requiring average annual EPS growth over the performance period to be in excess of 3 per cent as follows:
| Average annual EPS growth over the three-year performance period |
Percentage of shares subject to the EPS performance target that vest |
|---|---|
| 3% or less | 0% |
| More than 3% but less than 10% | On a straight line basis between 0% and 100% |
| 10% or more | 100% |
The other 50 per cent of each of these awards will be subject to a performance target requiring the Company's TSR to be at least at the median of the companies comprising the FTSE All-Share Index (excluding investment trusts). If it is, this part of an award will vest as follows:
| TSR ranking of the Company compared Percentage of shares subject to the TSR performance target that vest |
|---|
| 0% |
| 3.85% |
| On a straight line basis between 3.85% and 100% |
| 100% |
The Committee has the discretion to reduce the number of ordinary shares that vest to ensure that vesting outcomes are appropriate in light of the underlying business performance of the Company'.
The Committee may amend a performance target if an event occurs which causes the Committee to consider it appropriate to do so. The amended target shall not be materially more or less demanding to satisfy than the original performance target was when first set and must be a fairer measure of performance than the original performance target.
Awards granted to executive directors of the Company in future years may, subject to the Company's shareholder approved directors' remuneration policy, be granted subject to different performance targets to those described above provided that such other targets are not materially less challenging on grant than the performance targets described above were when the 2018 awards were granted.
Awards granted other than to executive directors of the Company may be subject to other performance targets or granted as Restricted Stock Awards.
Performance Share Awards will normally vest on the third anniversary of grant, subject to the satisfaction of the performance targets.
Restricted Stock Awards will vest at such time(s) as the Committee may specify on grant, although the intention in respect of the first grant of Restricted Stock Awards is for those awards to normally vest on the third anniversary of grant.
It is currently intended that Performance Share Awards granted to executive directors of the Company will be subject to a post-vesting holding period which will prevent the sale of any ordinary shares received pursuant to a Performance Share Award until the fifth anniversary of grant (other than those sold to raise funds to discharge the tax liabilities arising on vesting/exercise (as applicable)).
The current intention is also that the post-vesting holding period will apply notwithstanding that the participant has ceased employment with the Company's Group, although the Committee may terminate the post-vesting holding period early if the cessation occurs due to a good leaver reason referred to in section 9 or if there is a takeover of the Company.
Notwithstanding the above, the terms and basis upon which the post-vesting holding period will operate shall be determined by the Committee from time to time.
If a participant leaves employment with the Company's Group his award will normally lapse unless he is a 'good leaver'.
A participant will be a 'good leaver' if the reason for leaving is injury, ill-health, disability, redundancy, retirement (with the consent of the Committee), the sale of the employing business or company or otherwise at the discretion of the Committee.
If the participant is a good leaver then awards shall vest on the date on which they would have vested had the cessation not occurred subject to any performance targets being satisfied and, unless the Committee determines otherwise, a time pro-rata reduction to reflect the period of time between grant and cessation relative to the length of the vesting period.
The Committee may, alternatively, allow awards held by good leavers to vest before the normal vesting date subject to the satisfaction of any performance targets and, unless the Committee determines otherwise, a time pro-rata reduction as described above.
If the participant dies his award will vest on the date of death. The Committee may, alternatively, allow the award to vest on the normal vesting date (or such other date between the date of death and the normal vesting date as it sees fit). In all cases, vesting will be subject to any performance targets being met at the relevant time and, unless the Committee determines otherwise, a time pro-rata reduction as described above.
Where in certain circumstances a participant (other than an executive director of the Company) is transferred to work overseas his unvested award may vest at the discretion of the Committee.
Awards may be subject to withholding and/or recovery within three years from the date of vesting if the Committee determines that there has been a material misstatement of the Company's financial results, an error in assessing any applicable performance target or the participant's employment is terminated (or could have been summarily terminated) as a result of misconduct on the part of that individual. In these circumstances, the Committee may withhold or recover future incentive compensation, including but not limited to the amount of any unpaid bonus, the number of ordinary shares under a vested but unexercised LTIP 2018 award and/or a requirement to recover the value of any over-vesting by requiring the participant to make a cash payment to the Company.
In the event of a takeover of the Company, awards shall vest early on the following basis:
In the event of a demerger, delisting, special dividend or other event which, in the opinion of the Committee, would affect the market price of an ordinary share to a material extent the Committee may allow awards to vest on the basis described above. Awards will not normally vest on an internal reorganisation.
The Committee may decide that participants will receive a payment (in cash and/or ordinary shares) on or shortly following the settlement of their awards of an amount equivalent to the dividends that would have been paid on those ordinary shares between the time when the awards were granted and the time when they vest (or, where an award is structured as a nil or nominal cost option, the earlier of the exercise date and the date on which any applicable post-vesting holding period expires).
If there is any variation of the Company's ordinary share capital, or in the event of a demerger or payment of a special dividend or similar event which would otherwise materially affect the value of an award, the Committee may adjust the number of ordinary shares under award and the exercise price (if any).
Ordinary shares allotted or transferred under the LTIP 2018 will rank alongside shares of the same class then in issue. The Company will apply to the Financial Conduct Authority for the listing of any newly issued ordinary shares. Awards are not transferable (except on death) and are not pensionable benefits.
The Committee may amend the LTIP 2018 in any respect. However, the provisions governing eligibility, equity dilution, individual participation limits, the basis for determining the rights of participants to acquire ordinary shares or to receive cash and the adjustments that may be made following a variation of capital cannot be altered to the advantage of existing or new participants without the prior approval of shareholders in general meeting. There is an exception for minor amendments to benefit the administration of the LTIP 2018, to take account of a change in legislation or to obtain or maintain favourable tax, exchange control or regulatory treatment for participants in the LTIP 2018 or for any member of the Company.
This summary does not form part of the rules of the LTIP 2018 and should not be taken as affecting the interpretation of the detailed terms and conditions of the rules of the LTIP 2018. The Committee reserves the right up to the time of the AGM to make such amendments and additions to the rules of the LTIP 2018 as it sees fit provided that such amendments do not conflict in any material respect with this summary.
The UK SAYE Scheme 2018 will provide for eligible employees to be granted options to acquire ordinary shares in the Company.
Ordinary shares allotted under the UK SAYE Scheme 2018 will rank pari passu in all respects with all other ordinary shares then in issue, but will not participate in any dividend or other rights attaching to shares by reference to a record date preceding the date of exercise of an option.
All UK employees of Elementis plc and any subsidiaries which have been nominated as 'participating companies' ('Elementis Group') who have at least three months' continuous service prior to the invitation date will be eligible to participate in the UK SAYE Scheme 2018.
Participants will be required to enter into a three or five year savings contract with a bank or a building society to make fixed monthly savings contributions. At the end of the specified savings period a tax free bonus will be payable by the savings carrier. Participants may use their savings and the bonus to acquire ordinary shares on the exercise of their options.
The number of ordinary shares over which an option may be granted is limited to that number which may be purchased at the exercise price out of the anticipated proceeds of the savings account at maturity. Participants may save up to the maximum monthly amount allowed under the legislation (currently £500 a month) although the Board of directors of Elementis plc ('Board') may set a lower limit.
Invitations to apply for options may normally only be issued within 42 days of the announcement of the Company's results for any year, half-year or other period. No options may be granted more than ten years after the approval of the UK SAYE Scheme 2018 by shareholders.
The Board may decide to impose a limit on the number of shares available for the grant of options under the UK SAYE Scheme 2018 on a particular occasion, and if it does so, this limit must be notified to all eligible employees in the invitation.
If an invitation is over-subscribed and the applications for options exceed the number of shares available for the grant of options, the rules permit the Board to 'scale down' applications to ensure that the limit is not exceeded.
The price at which participants may acquire shares is fixed by the Board when the option is granted, and may not be less than the greater of (i) 80 per cent of the market value of an ordinary share (being the average of the middle market quotations for the five dealing days immediately preceding the day on which invitations are issued under the UK SAYE Scheme); and (ii) the nominal value of such shares.
The limit on the number of ordinary shares which may be issued pursuant to options granted under UK SAYE Scheme 2018 is that, in any ten year period, not more than 10 per cent of Elementis plc's issued ordinary share capital for the time being may be allocated under all Elementis Group employee share schemes. For the purpose of this limit, any options which lapse in accordance with the rules of the UK SAYE Scheme 2018 cease to count.
An option may only be exercised by the person to whom it is granted or, on his/her death, his/her personal representatives and is not transferable. Benefits receivable under the UK SAYE Scheme 2018 will not be pensionable.
Options will normally only be exercisable for a period of six months commencing on the date the tax free bonus becomes payable under the savings contract. If an option is not exercised by the end of that period it will lapse. Options may, however, be exercised earlier than this in certain specified circumstances including death or on leaving employment on account of injury, disability, redundancy, retirement, or in the event of the sale of the business or subsidiary for which the individual works. Options which have been held for at least three years may also be exercised in circumstances which the Board considers to be retirement or voluntary redundancy. Options may also be exercised for a limited period after a takeover, reconstruction or amalgamation or a voluntary winding up of Elementis plc. In the event of a takeover or reconstruction, a participant may be permitted to exchange his/her option for an option over shares in the acquiring company. In all such cases of early exercise, an option may be exercised only to the extent of the participant's savings (plus any interest that is due under the relevant savings contract) at that time.
In the event of any rights or capitalisation issues, or of any reduction, subdivision, consolidation or other variation of share capital, the option price and/or the number of ordinary shares over which options have been granted may be adjusted.
The UK SAYE Scheme 2018 cannot be amended to the advantage of option holders without the prior approval of shareholders in general meeting (except amendments which the Board considers necessary or desirable to benefit its administration, to take account of a change in legislation or to obtain or maintain favourable tax, exchange control or regulatory treatment for option holders or for any member of the Elementis Group). If it is intended that the UK SAYE Scheme 2018 is to retain the associated tax benefits, no amendment to a 'key feature' of the UK SAYE Scheme 2018 can be made.
These documents will also be available for inspection at the offices of Herbert Smith Freehills LLP, Exchange House, Primrose Street, London EC2A 2EG for not less than 15 minutes prior to and during the AGM.
CREST members who wish to appoint one or more proxies through the CREST system may do so by using the procedures described in 'the CREST voting service' section of the CREST Manual. CREST personal members or other CREST sponsored members, and those CREST members who have appointed one or more voting service providers, should refer to their CREST sponsor or voting service provider(s), who will be able to take the appropriate action on their behalf. In order for a proxy appointment or a proxy instruction made using the CREST voting service to be valid, the appropriate CREST message (a 'CREST proxy appointment instruction') must be properly authenticated in accordance with the specifications of CREST's operator, Euroclear UK & Ireland Limited ('Euroclear'), and must contain all the relevant information required by the CREST Manual (www.euroclear.com). To be valid the message, regardless of whether it constitutes the appointment of a proxy or is an amendment to the instruction given to a previously appointed proxy, must be transmitted so as to be received by Equiniti Limited (ID RA19), as the Company's 'issuer's agent', by 11.00 am on 24 April 2018. After this time any change of instruction to a proxy appointed through the CREST system should be communicated to the appointee through other means. The time of the message's receipt will be taken to be when (as determined by the timestamp applied by the CREST Applications Host) the issuer's agent is first able to retrieve it by enquiry through the CREST system in the prescribed manner.
The Group operates a website which can be found at www.elementisplc.com. This site is frequently updated to provide shareholders with information about the Group. In particular, the Group's press releases and announcements can be found on the site together with copies of the Group's accounts.
Enquiries concerning shares or shareholdings, such as the loss of a share certificate, consolidation of share certificates, amalgamation of holdings or dividend payments, should be made to the Company's registrars:
Equiniti Limited Aspect House Spencer Road Lancing West Sussex BN99 6DA
Tel: 0371 384 2379 or +44 (0)121 415 7043
Lines are open 8.30 am to 5.30 pm, Monday to Friday (excluding public holidays in England and Wales).
In any correspondence with the registrars, please refer to Elementis plc and state clearly the registered name and address of the shareholder. Please notify the registrars promptly of any change of address.
It is in the best interests of shareholders and the Company for dividends to be paid directly into bank or building society accounts. Any shareholder who wishes to receive dividends in this way should contact the Company's registrars to obtain a dividend mandate form.
For shareholders with hearing difficulties: Callers inside the UK telephone: 0371 384 2255 Callers outside the UK telephone: +44 (0)121 415 7028
Equiniti provides a range of shareholders' services online. The portfolio service provides access to information on share balances, balance movements, indicative share prices and information on recent dividends and also enables address and dividend mandate details to be amended online. For further information and practical help on transferring shares or updating your details, please visit www.shareview.co.uk.
Equiniti also provides a share dealing service that enables shares to be bought or sold by UK shareholders by telephone or over the internet. For telephone share dealing please call 0345 603 7037 between 8.30 am and 4.30 pm (lines are open until 6.00 pm for enquiries) and for internet share dealing please visit: www.shareview.co.uk/dealing.
Laura Higgins
Caroline House 55-57 High Holborn London WC1V 6DX UK
3299608
Deloitte LLP
UBS Investment Bank N+1 Singer
Tulchan Communications
| 27 February 2018 | Preliminary announcement of final results for the year ended 31 December 2017 |
|---|---|
| 26 April 2018 | Annual General Meeting |
| 26 April 2018* | Trading update |
| 3 May 2018 | Ex-dividend for final dividend for 2017 payable on ordinary shares |
| 4 May 2018 | Record date for final dividend for 2017 payable of ordinary shares |
| 1 June 2018 | Payment of final dividend for 2017 on ordinary shares |
| 31 July 2018* | Interim results announcement for the half year ending 30 June 2018 |
| 6 September 2018* | Ex-dividend date for interim dividend for 2018 payable on ordinary shares |
| 7 September 2018* | Record date for interim dividend for 2018 payable on ordinary shares |
| 28 September 2018* | Payment of interim dividend for 2018 on ordinary shares |
* Provisional date
Elementis plc Caroline House 55-57 High Holborn London WC1V 6DX UK
Tel: +44 (0) 20 7067 2999 Fax: +44 (0) 20 7067 2998
Email: [email protected] Website: www.elementisplc.com
Elementis Global 469 Old Trenton Road East Windsor NJ 08512 US
Tel: +1 609 443 2000
Websites: www.elementis.com (Specialty Products)
www.elementischromium.com (Chromium)
Caroline House 55-57 High Holborn London WC1V 6DX UK
Tel: +44 (0) 20 7067 2999 Fax: +44 (0) 20 7067 2998
WWW.ELEMENTISPLC.COM
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.